Arrue Lily, Ratjen Lars
Facultad de Ciencias Biológicas, Center for Bioinformatics and Integrative Biology (CBIB), Universidad Andres Bello, Av. Republica 239, Santiago, Chile.
Fundación Fraunhofer Chile Research, Mariano Sánchez Fontecilla 310, Piso 14, Las Condes, Santiago, Chile.
ChemMedChem. 2017 Dec 7;12(23):1908-1916. doi: 10.1002/cmdc.201700621. Epub 2017 Nov 14.
The photochemical control of structure and reactivity bears great potential for chemistry, biology, and life sciences. A key feature of photochemistry is the spatiotemporal control over secondary events. Well-established applications of photochemistry in medicine are photodynamic therapy (PDT) and photopharmacology (PP). However, although both are highly localizable through the application of light, they lack cell- and tissue-specificity. The combination of nanomaterial-based drug delivery and targeting has the potential to overcome limitations for many established therapy concepts. Even more privileged seems the merger of nanomedicine and cell-specific targeting (internal targeting) controlled by light (external control), as it can potentially be applied to many different areas of medicine and pharmaceutical research, including the aforementioned PDT and PP. In this review a survey of the interface of photochemistry, medicine and targeted drug delivery is given, especially focusing on phototriggered targeting in nanomedicine.
结构与反应性的光化学控制在化学、生物学和生命科学领域具有巨大潜力。光化学的一个关键特性是对次级事件的时空控制。光化学在医学上已确立的应用是光动力疗法(PDT)和光药理学(PP)。然而,尽管两者都可通过光的应用实现高度局部化,但它们缺乏细胞和组织特异性。基于纳米材料的药物递送与靶向相结合,有可能克服许多既定治疗概念的局限性。纳米医学与受光控制的细胞特异性靶向(内部靶向)(外部控制)的融合似乎更具优势,因为它有可能应用于医学和药物研究的许多不同领域,包括上述的PDT和PP。在本综述中,对光化学、医学和靶向药物递送的界面进行了概述,尤其关注纳米医学中的光触发靶向。